68-3

95/130

) Fujihira H, Masahara-Negishi Y, Akimoto Y, Hirayama H, Lee H.C, Story B.A, Mueller W.F, Jakob P, Clauder-Munster S, Steinmetz L.M, Radhakrishnan S.K, Kawakami H, Kamada Y, Miyoshi E, Yokomizo T, Suzuki T: Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metab-olism under food stress. Biochim Biophys Acta Mol Basis Dis, 2020; 1866: 165588.) Ueno T, Komatsu M: Monitoring Autophagy Flux and Activity: Principles and Applica-tions. Bioessays, 2020; 42: e2000122. doi: 10. 1002/bies.202000122. Epub 2020 Aug 26.Goullee H, Andersen E, McLean C, Davis M, Ishimura R, Stark Z, Vallat JM, Komatsu M, Kornberg A, Ryan M, Laing NG, Ravenscroft G: A homozygous UBA5 pathogenic variant causes a fatal congenital neuropathy. J Med Genet, 2020; 57: 835-842. doi: 10.1136/jmed-genet-2019-106496. Epub 2020 Mar 16.) Sánchez-Martín P, Sou YS, Kageyama S, Koike M, Waguri S, Komatsu M: NBR1-medi-ated p62-liquid droplets enhance the Keap1- Nrf2 system. EMBO Rep, 2020; 21: e48902. doi: 10.15252/embr.201948902. Epub 2020 Jan 9.) Yasuda D, Ohe T, Takahashi K, Imamura R, Kojima H, Okabe T, Ichimura Y, Komatsu M, Yamamoto M, Nagano T, Mashino T: Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line. Free Radic Res, 2020; 30: 1-13. doi: 10.1080/10715762.2020.1732955.) Nakamura S, Shigeyama S, Minami S, Shima T, Akayama S, Matsuda T, Esposito A, Napol-itano G, Kuma A, Namba-Hamano T, Nakamura J, Yamamoto K, Sasai M, Tokumura A, Miya-moto M, Oe Y, Fujita T, Terawaki S, Taka-hashi A, Hamasaki M, Yamamoto M, Okada Y, Komatsu M, Nagai T, Takabatake Y, Xu H, Isaka Y, Ballabio A, Yoshimori T: LC3 lipi-dation is essential for TFEB activation during the lysosomal damage response to kidney injury. Nat Cell Biol, 2020; 22: 1252-1263. doi: 10.1038/s41556-020-00583-9. Epub 2020 Sep 28.) Aragonès G, Dasuri K, Olukorede O, Fran-cisco SG, Renneburg C, Kumsta C, Hansen M, Kageyama S, Komatsu M, Rowan S, Volkin J, Workman M, Yang W, Daza P, Ruano D, Dominguez-Martín H, Rodríguez-Navarro JA, Du XL, Brownlee MA, Bejarano E, Taylor A: Autophagic receptor p62 protects against glycation-derived toxicity and enhances viability. Aging Cell, 2020; 19: e13257. doi: 10.1111/acel.13257. Epub 2020 Nov 4. 3 4 5 6〈Reviews〉 1291Molecular and Cellular Biochemistory〈Original Articles〉 1† 2) Han B, Lee-Okada H.C, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T: Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells. FEBS Open Bio, 2020.) Horii Y, Nakaya M, Ohara H, Nishihara H, Watari K, Nagasaka A, Nakaya T, Sugiura Y, Okuno T, Koga T, Tanaka A, Yokomizo T, Kurose H: Leukotriene B4 receptor 1 exacer-bates inflammation following myocardial infarc-tion. FASEB Journal, 2020; 34: 8749-8763.) Hosooka T, Hosokawa Y, Matsugi K, Shino-hara M, Senga Y, Tamori Y, Aoki C, Matsui S, Sasaki T, Kitamura T, Kuroda M, Sakaue H, Nomura K, Yoshino K, Nabatame Y, Itoh Y, Yamaguchi K, Hayashi Y, Nakae J, Accili D, Yokomizo T, Seino S, Kasuga M, Ogawa W: The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B4 axis. Proceedings of the National Academy of Sciences of the United States of America, 2020; 117: 11674-11684.) Ishihara E, Nagaoka Y, Okuno T, Kofuji S, Ishigami-Yuasa M, Kagechika H, Kamimura K, Terai S, Yokomizo T, Sugimoto Y, Fujita Y, Suzuki A, Nishina H: Prostaglandin E2 and its receptor EP2 trigger signaling that contributes to YAP-mediated cell competi-tion. Genes to Cells, 2020; 25: 197-214. 3 4 5＊ 6) Ishizuka K, Kon K, Lee-Okada H.C, Arai K, Uchiyama A, Yamashina S, Yokomizo T, Ikejima K: Aging exacerbates high-fat diet-induced steatohepatitis through alter-ation in hepatic lipid metabolism in mice. Journal of Gastroenterology and Hepatology,